RxDoctor Payments Data

Patricia Limbaugh, NP

Family · Garland, TXNPI 1568921989

Payments from drug & device makers

$1,916in general payments, 2019–2025

Across 105 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$240
  • Pfizer$197
  • Lilly USA, LLC$177
  • Astellas Pharma US Inc$175
  • AbbVie$159
  • Organon$155
  • plus $812 from 17 others

What the payments were for

  • Food & beverage$1,83796%
  • Education$794%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,916 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$45,946
Medicare patients
181
Services billed
1,728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$28,874
XareltoRivaroxaban13$12,749
Gabapentin50$827
Ipratropium Bromide21$826
Estradiol12$817
Levothyroxine Sodium70$739
Duloxetine Hcl31$733
Levocetirizine Dihydrochloride21$668
Montelukast Sodium34$532
Albuterol Sulfate HfaAlbuterol Sulfate17$518
Losartan Potassium58$516
Bupropion XlBupropion Hcl22$494
Atorvastatin Calcium65$476
Rosuvastatin Calcium54$448
Omeprazole24$434

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$88$28,87420 claims
Johnson & JohnsonXarelto$35$12,74913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 15,456 family providers in Texas.

Other family in Garland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →